ARID1A and ARID2 are often mutated in HCC patients, with ARID1A mutations supporting metastatic progression and ARID2 mutations increasing DNA damage via impaired nuclear excision repair [219,220]. Here, ARID2 is linked to hepatocellular carcinoma.